Overall survival predictors in hepatocellular carcinoma patients treated with sorafenib

Overall survival predictors in hepatocellular carcinoma patients treated with sorafenib

SUMMARY Malignant liver tumors are the fourth leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) accounts for 75-85% of these. Most patients are diagnosed at incurable stages. Palliative care is the appropriate treatment course in these circumstances (chemoembolization and soraf...

Full description

Bibliographic Details
Main Authors: Caroline Petersen da Costa Ferreira, Mauricio Alves Ribeiro, Luiz Arnaldo Szutan
Format: Article
Language:English
Published: Associação Médica Brasileira
Series:Revista da Associação Médica Brasileira
Subjects:
neoplasias hepáticas
carcinoma hepatocelular
sorafenibe
inibidores de proteínas quinases
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020000300275&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020000300275&lng=en&tlng=en

Similar Items